BCAL Diagnostics Limited (AU:BDX) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
BCAL Diagnostics Limited announces the quotation of 3 million fully paid ordinary shares on the Australian Securities Exchange (ASX), following shareholder approval at the recent Annual General Meeting. This move marks a significant step for the company, potentially attracting investor interest and impacting stock market dynamics.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.